MARIA JOSE
GIMENEZ MESTRE
PROFESOR ACREDITADO
Publications (184) MARIA JOSE GIMENEZ MESTRE publications
2024
-
Assessing the Impact of COVID-19 on Amateur Runners’ Performance: An Analysis through Monitoring Devices
Sensors, Vol. 24, Núm. 8
-
Effects of Minimalist vs. Traditional Running Shoes on Abdominal Lumbopelvic Muscle Activity in Women Running at Different Speeds: A Randomized Cross-Over Clinical Trial
Sensors, Vol. 24, Núm. 2
2023
-
Critical appraisal beyond clinical guidelines for intraabdominal candidiasis
Critical Care, Vol. 27, Núm. 1
-
Differences between Novice and Expert Raters Assessing Trunk Control Using the Trunk Control Measurement Scale Spanish Version (TCMS-S) in Children with Cerebral Palsy
Journal of Clinical Medicine, Vol. 12, Núm. 10
-
Physiotherapy applied to palliative care patients: a descriptive practice-based study
BMC Palliative Care, Vol. 22, Núm. 1
2022
-
Predictive Validity of the Postural Assessment Scale for Stroke (PASS) to Classify the Functionality in Stroke Patients: A Retrospective Study
Journal of Clinical Medicine, Vol. 11, Núm. 13
2019
-
Critically ill patients with community-onset intraabdominal infections: Influence of healthcare exposure on resistance rates and mortality
PLoS ONE, Vol. 14, Núm. 9
-
Evaluating the optimal time for amikacin administration with respect to haemodialysis using an in vitro pharmacodynamic simulation against epidemic nosocomial OXA-48 producing Klebsiella pneumoniae ST405 strains
Journal of Global Antimicrobial Resistance, Vol. 19, pp. 241-251
-
Factors associated with development of nephrotoxicity in patients treated with vancomycin versus daptomycin for severe Gram-positive infections: A practice-based study
Revista Espanola de Quimioterapia, Vol. 32, Núm. 1, pp. 22-30
2018
-
Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients
Critical Care, Vol. 22, Núm. 1
-
Revisiting cefditoren for the treatment of community-acquired infections caused by human-adapted respiratory pathogens in adults
Multidisciplinary Respiratory Medicine, Vol. 13, Núm. 1
2017
-
Development of Aspergillosis in a cohort of non-neutropenic, non-transplant patients colonised by Aspergillus spp
BMC Infectious Diseases, Vol. 17, Núm. 1
-
Factores de riesgo para la colonización por enterobacterias productoras de carbapenemasas en el momento de admisión en una UCI quirúrgica: estudio retrospectivo
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 35, Núm. 6, pp. 333-337
2016
-
Basis for selecting optimum antibiotic regimens for secondary peritonitis
Expert Review of Anti-Infective Therapy, Vol. 14, Núm. 1, pp. 109-124
-
Intraabdominal candidiasis in surgical ICU patients treated with anidulafungin: A multicenter retrospective study
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 29, Núm. 1, pp. 32-39
2015
-
Biomarkers (procalcitonin, C reactive protein, and lactate) as predictors of mortality in surgical patients with complicated intra-abdominal infection
Surgical Infections, Vol. 16, Núm. 3, pp. 346-351
-
Estudio observacional basado en la práctica clínica sobre la utilización de micafungina en Unidades de Cuidados Críticos Quirúrgicos
Revista Espanola de Quimioterapia, Vol. 28, Núm. 3, pp. 132-138
-
Estudio observacional basado en la práctica diaria identificando factores asociados con la administración de dosis altas de tigeciclina en el tratamiento de la peritonitis secundaria en pacientes críticos
Revista Espanola de Quimioterapia, Vol. 28, Núm. 1, pp. 47-53
-
Procalcitonin-guided therapy may reduce length of antibiotic treatment in intensive care unit patients with secondary peritonitis: A multicenter retrospective study
Journal of Critical Care, Vol. 30, Núm. 3, pp. 537-542
-
Secular trends (1990-2013) in serotypes and associated non-susceptibility of S. pneumoniae isolates causing invasive disease in the pre-/post-era of pneumococcal conjugate vaccines in Spanish regions without universal paediatric pneumococcal vaccination
Vaccine, Vol. 33, Núm. 42, pp. 5691-5699